Toucan Capital

Founded 2001

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 8
Average round size
info
The average size of a deal this fund participated in
$8M
Portfolio companies 5
Rounds per year 0.40
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.38
Exits 2
Key employees 2
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Renewable Energy
  • Advanced Materials
  • Energy
  • Nanotechnology
Summary

Toucan Capital is the famous VC, which was founded in 2001. The main department of described VC is located in the Bethesda. The fund was located in North America if to be more exact in United States.

Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has specific favorite in a number of founders of portfolio startups. Among the various public portfolio startups of the fund, we may underline Intrapace, Pepgen Corporation, Q Therapeutics Among the most popular fund investment industries, there are Medical, Clinical Trials.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Toucan Capital, startups are often financed by Silicon Alley Venture Partners, Sevin Rosen Funds, Next47. The meaningful sponsors for the fund in investment in the same round are Silicon Alley Venture Partners, Sevin Rosen Funds, Next47. In the next rounds fund is usually obtained by Sevin Rosen Funds, Silicon Alley Venture Partners, Next47.

The fund is generally included in less than 2 deals every year. Comparing to the other companies, this Toucan Capital performs on 15 percentage points less the average number of lead investments. Deals in the range of 5 - 10 millions dollars are the general things for fund. The top amount of exits for fund were in 2009. Considering the real fund results, this VC is 9 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2004.

Read more

Funds with similar focus

Funds from United States, Bethesda
Funds with similar focus located in United States, Bethesda:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Purple Arch Ventures United States, Chicago
F50 United States, Austin
Fannin Innovation Studio United States, Houston
Drobny Global Advisors United States, Manhattan Beach
Cars.com United States, Chicago
The Phoenix Partners United States, Seattle
Associated Bank United States, Green Bay
Reservoir Investment Managers India, Bangalore
Veritech Ventures United States, New York
China Mobile Innovation Industry Fund China, Beijing
Ashwin LLC -
Wyndcrest Partners -
FIDURA Capital Consult Germany, München
Digital Hollywood Japan, Tokyo
Force Ventures Germany, Berlin
Oriental Bank Of Commerce India, Gurgaon
RAIN Source Capital United States, Minneapolis
Fannin Innovation Studio -
Orion Resource Partners United States, New York
Greater Manchester Cyber Foundry -
Sidecar Fund2 -

Notable deals

CompanyIndustryRoundRound SizeDateInvestorsLocation

INmuneBIO

Biotechnology
Commercial
Industrial
Medical
1
$7M10 Jun 2019 United States, San Diego

Reactive NanoTechnologies

Advanced Materials
Energy
Manufacturing
Nanotechnology
Renewable Energy
1
$4M02 May 2008 United States, " United States"}

Q Therapeutics

Biotechnology
Health Care
Therapeutics
n/a
$15M15 Feb 2008 United States, Salt Lake City

Reactive NanoTechnologies

Advanced Materials
Energy
Manufacturing
Nanotechnology
Renewable Energy
1
$6M07 Jan 2008 United States, " United States"}

Pepgen

Biotechnology
Clinical Trials
Medical
1
$7M03 Aug 2004 United Kingdom, Oxford

Intrapace

Biotechnology
Health Care
Health Diagnostics
1
$14M14 Jul 2004 United States, San Jose

Reactive NanoTechnologies

Advanced Materials
Energy
Manufacturing
Nanotechnology
Renewable Energy
1
$8M05 Mar 2004 United States, " United States"}

Reactive NanoTechnologies

Advanced Materials
Energy
Manufacturing
Nanotechnology
Renewable Energy
1
$1M03 Jan 2003 United States, " United States"}

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Toucan Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: